期刊文献+

抗菌药物体外敏感性实验的结果分析方法研究 被引量:1

A New method to analyze the results in antimicrobial susceptibility testing
下载PDF
导出
摘要 目的建立新的抗菌药物体外敏感性实验数据处理方法,为更加科学全面评价新型抗菌药物的抗菌疗效提供方法学依据。方法对5个受试样品体外细菌敏感性试验结果进行概率分析,采用MATLAB2007B软件,对药物量效关系的各模型进行编程拟合,以残差平方和与相关系数为主要判别,进行线性、对数线性、Emax和Sigmod Emax模型的对比。结果各组数据均以Sigmod Emax拟合较优,因此,选取其为最终数据的拟合模型,并计算ED50和Emax。结论数据结果能反应药物的作用效应,建议在药物体外敏感性试验结果分析中,采用该种分析方法。 Objective To establish a new method to analyze the data of antimicrobial susceptibility testing, and to provide basis for a more scientific and comprehensive evaluation of antibacterial efficacy. Method This paper performed profit analyses and used MATLAB2007B to analyze the sensitivity testing results in 5 subject samples. The drug dose-response relationship for each model was programmed to fit the model. The results were compared with linear.logarithmic linear.Emax and Sinmod Emax models,using residual square sum and correlation coefficient as the main criteria. Result The results show that the data of each group were Sigmod Emax fitting better. Therefore,choosing the Sigmod Emax is as the final data fitting model. Conclusion The results provide a better method to analyze the data of antimicrobial susceptibility testing.
机构地区 成都中医药大学
出处 《成都医学院学报》 CAS 2012年第4期579-581,共3页 Journal of Chengdu Medical College
基金 成都中医药大学科技创新基金
关键词 抗菌 药物敏感性试验 概率分析 Antibiosis Antimicrobial susceptibility testing profit analysis
  • 相关文献

参考文献3

二级参考文献12

  • 1王超,王婧.耐甲氧西林金黄色葡萄球菌的临床治疗[J].中国医刊,2007,42(3):18-20. 被引量:10
  • 2FDA. Guidance for Industry Updating Labeling for Suscepti- bility Test Information in Systemic Antibacterial Drug Products and Antimierobial Susceptibility Testing Devices. June 2009 [EB/OL] . (2009 06 26) [2011-07-11]. http: // www. fda. gov/downloads/Drugs/GuidanceComplianceRegu latoryInformation/Guidances/UCM169359, pdf.
  • 3FDA. Under section 514 (c) of the Act, FDA has authority to recognize a standard for use by device manufacturers. The procedures for devices are described, in general, in a separate guidance from CDRH on Recognition and Use of Consensus Standards available at [EB/OL]. [2011 07-11]. http: // www. fda. gov/MedicalDevices/DevieeRegulationandGuid ance/default, htm.
  • 4FDA. GuidanceComplianceRegulatorylnformation/Guidances/ UCM169359. pdf. See [EB/OL]. [2011-07-111. http: // www. fda. gov/Forlndustry/DataStandards/StructuredProduct- Labeling/default. htm.
  • 5FDA. The Class I1 Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems; Guidance for Industry is available at [EB/OL]. [2011-07-11]. ht- tp.. //www. fda. gov/MedicalDevices/DeviceRegulation- andGuidance/GuidanceDocuments/ucm080564, htm. FDA intends to update the Class II special controls guidance docu- ment to incorporate the information above.
  • 6Could SW, Cuschieri P, Rollason J, et al. The need for continued monitoring of antibiotic resistance patterns in clinical isolates of Staphylococcus aureus from London and Maita[J]. Ann Clin Mierobiol Antimicrob, 2010,21 : 20.
  • 7杨雪云,赵博光,巨云为.苦参碱和氧化苦参碱的抑菌活性及增效作用[J].南京林业大学学报(自然科学版),2008,32(2):79-82. 被引量:31
  • 8邓永中,陆梦怡.中药抗菌有效化学物质的研究进展[J].中国现代药物应用,2008,2(18):110-112. 被引量:10
  • 9贾伟,李刚,赵志军,师志云,杨晓燕,魏军.医院环境MRSA流行病学调查[J].中华医院感染学杂志,2010,20(6):818-820. 被引量:14
  • 10张立明,杨凤琴,袁本香,马健国.沙棘总黄酮对4种念珠菌的体外抑菌作用[J].中国医院药学杂志,2010,30(16):1355-1357. 被引量:17

共引文献13

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部